J&J wins FDA approval for diabetes combo; What do the FDA's social media guidelines mean for digital marketers?;

> The FDA has approved Johnson & Johnson's ($JNJ) diabetes combo of Invokana and metformin. Story

> Johnson & Johnson's ($JNJ) Janssen Pharmaceuticals has extended its partnership with NASCAR and will sponsor the first race in the Sprint Cup Series as part of its activities around National AFib Awareness Month. Story

> Janssen has launched an online mental health video series, Healthy Minds, that will focus on brain disorder research and treatment. Story

> Sanofi ($SNY) has launched an authorized generic of colorectal cancer drug Eloxatin. Release

> Vaccinemaker PaxVax has named Jonathan Klock as its North American sales and marketing VP and Jeremy Gowler as its VP of global marketing. Release

And Finally... What do the FDA's social media guidelines mean for SEO and digital marketers in the pharma industry? Blog

Suggested Articles

Only months removed from a gamechanging label expansion for Vascepa, Amarin is scrambling after a district judge invalidated the drug's key patents.

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.